Monotetradecylsulfate sodium salt
Brand names,
Monotetradecylsulfate sodium salt
Analogs
Monotetradecylsulfate sodium salt
Brand Names Mixture
Monotetradecylsulfate sodium salt
Chemical_Formula
C14H30O4S
Monotetradecylsulfate sodium salt
RX_link
http://www.rxlist.com/cgi/generic2/sotradecol.htm
Monotetradecylsulfate sodium salt
fda sheet
Monotetradecylsulfate sodium salt
msds (material safety sheet)
Monotetradecylsulfate sodium salt
Synthesis Reference
No information avaliable
Monotetradecylsulfate sodium salt
Molecular Weight
294.452 g/mol
Monotetradecylsulfate sodium salt
Melting Point
No information avaliable
Monotetradecylsulfate sodium salt
H2O Solubility
No information avaliable
Monotetradecylsulfate sodium salt
State
Solid
Monotetradecylsulfate sodium salt
LogP
No information avaliable
Monotetradecylsulfate sodium salt
Dosage Forms
Solution for intramuscular injection
Monotetradecylsulfate sodium salt
Indication
For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.
Monotetradecylsulfate sodium salt
Pharmacology
Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.
Monotetradecylsulfate sodium salt
Absorption
No information avaliable
Monotetradecylsulfate sodium salt
side effects and Toxicity
LD50=1250 mg/kg (Orally in rat); LD50=3 ml/kg (Skin in rat)
Monotetradecylsulfate sodium salt
Patient Information
No information avaliable
Monotetradecylsulfate sodium salt
Organisms Affected
Humans and other mammals